1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Fecal Immunochemical Diagnostic Test (FIT) Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Regulatory Scenario
5.3. Pricing Analysis
5.4. COVID-19 Pandemic Impact on Industry
6. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Kits & Reagents
6.3.2. Analyzers
6.3.3. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals & Diagnostic Laboratories
7.3.2. Specialty Clinics
7.3.3. Home Care Settings
7.3.4. Research Institutes
7.4. Market Attractiveness Analysis, by End-user
8. Global Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017-2031
9.2.1. Kits & Reagents
9.2.2. Analyzers
9.2.3. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals & Diagnostic Laboratories
9.3.2. Specialty Clinics
9.3.3. Home Care Settings
9.3.4. Research Institutes
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Kits & Reagents
10.2.2. Analyzers
10.2.3. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals & Diagnostic Laboratories
10.3.2. Specialty Clinics
10.3.3. Home Care Settings
10.3.4. Research Institutes
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Kits & Reagents
11.2.2. Analyzers
11.2.3. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals & Diagnostic Laboratories
11.3.2. Specialty Clinics
11.3.3. Home Care Settings
11.3.4. Research Institutes
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Kits & Reagents
12.2.2. Analyzers
12.2.3. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals & Diagnostic Laboratories
12.3.2. Specialty Clinics
12.3.3. Home Care Settings
12.3.4. Research Institutes
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Kits & Reagents
13.2.2. Analyzers
13.2.3. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals & Diagnostic Laboratories
13.3.2. Specialty Clinics
13.3.3. Home Care Settings
13.3.4. Research Institutes
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2022
14.3. Company Profiles
14.3.1. Quest Diagnostics Incorporated
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Sentinel CH. SpA
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. FUJIFILM Corporation
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Quidel Corporation
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Danaher (Beckman Coulter, Inc.)
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Eiken Chemical Co., Ltd.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Freenome Holdings, Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Immunostics, Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. BTNX, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Biohit Oyj
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
Table 01: Global Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 06: North America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 09: Europe Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 12: Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 15: Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
Table 18: Middle East and Africa Fecal Immunochemical Diagnostic Test (FIT) Market Size (US$ Mn) Forecast, by End-user, 2017-2031
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer